Global healthcare AI innovator Qure.ai has raised $65 million in a Series D funding round led by Lightspeed and 360 ONE Asset, joined by Merck Global Health Innovation Fund and Kae Capital.
The round also saw participation from existing investors, including Novo Holdings, Health Quad, and TeamFund.
Also Read: Healthtech startup Visit Health raises over Rs 250 cr from PB Fintech’s arm
According to the company, the fresh investment will be used to expedite expansion into the US market and other geographies, increase investment in foundational AI models and enable complementary med-tech company acquisitions.
“Qure.ai has become a trusted medical imaging AI partner to hospitals and healthcare organisations around the world. Our work is helping to unlock clinical efficiencies and drive up the standard of care delivered to patients in the focus areas of TB, Lung Cancer and Stroke”, Prashant Warier, Co-founder and CEO of Qure.ai, said in a statement.
“This Series D round is an exciting step forward in our journey and will propel us forward in our mission to reach a billion patients through our solutions,” he added.
Qure.ai was founded in 2016. The company aims to make healthcare more accessible and equitable globally.
Also Read: Digital mental health startup Spring Health raises $100 mn, valuation jumps to $3.3 bn
Qure.ai solutions are deployed in over 90 countries across more than 3,000 sites, powering the efficient identification and management of critical diseases.
“With diagnostic specificity and sensitivity at levels rivaling radiologists and physicians, Qure is making quality healthcare accessible in the US and Europe as well as globally in Asia, Africa and Latin America,” said Dev Khare, Partner, Lightspeed.
Qure.ai is headquartered in Mumbai, with regional offices in New York, London, and Dubai.